Is the treatment of lung cancer in Norway adequate?

Almost 2,000 new cases of lung cancer are reported in Norway every year. Only 16-17% are operated upon with resection. Over the 1995-98 period, 1,035 not resected cases with localized lung cancer were reported to the Cancer Registry of Norway; 166 cases were excluded for various reasons. Records fro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tidsskrift for den Norske Lægeforening 2002-09, Vol.122 (23), p.2258-2262
Hauptverfasser: Rostad, Hans, Naalsund, Anne, Norstein, Jarle, Jacobsen, Randi, Aaløkken, Trond Mogens
Format: Artikel
Sprache:nor
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2262
container_issue 23
container_start_page 2258
container_title Tidsskrift for den Norske Lægeforening
container_volume 122
creator Rostad, Hans
Naalsund, Anne
Norstein, Jarle
Jacobsen, Randi
Aaløkken, Trond Mogens
description Almost 2,000 new cases of lung cancer are reported in Norway every year. Only 16-17% are operated upon with resection. Over the 1995-98 period, 1,035 not resected cases with localized lung cancer were reported to the Cancer Registry of Norway; 166 cases were excluded for various reasons. Records from the Cancer Registry with additional information from clinicians were revised by the authors with regard to staging and operability. Of 869 evaluable patients, 386 were inoperable due to advanced disease, and in 86 the situation was not adequately clarified. Of the remaining 397, 270 were classified as being operable and 127 possibly operable. Of the operable patients, small cell lung cancer was considered as the sole contraindication to surgery in 61 patients despite being in stage 1. Poor lung function was noted as contraindication to surgery in 50 patients. However, most of them were inadequately investigated. In 124 patients one or more other risk factors were considered as contraindications, but the impact of some of them seemed to have been overestimated. The study showed that the information about stage routinely submitted to the Cancer Registry was unsatisfactory. We believe that more patients with localized disease in the present series should have been operated on.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72713241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72713241</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-31ecdd6d715bd2061bd05a6c2bc57c1c837c7f0d0059bf45969e079f521ff20d3</originalsourceid><addsrcrecordid>eNo1j81KAzEYRbNQbK19BcnK3cCXZJJMViLFn0LRTfdDJvlSR-avSQbp21uwXR0uHC6cG7IE4KbgAGxB7lP6Oc9KMXNHFoyXZcWVWBKxTTR_I80Rbe5xyHQMtJuHA3V2cBhpO9DPMf7aE7Uej7PN-PxAboPtEq4vXJH92-t-81Hsvt63m5ddMclSFIKh8155zWTjOSjWeJBWOd44qR1zldBOB_AA0jShlEYZBG2C5CwEDl6syNP_7RTH44wp132bHHadHXCcU625ZoKX7Cw-XsS56dHXU2x7G0_1tVL8Ae5SS68</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72713241</pqid></control><display><type>article</type><title>Is the treatment of lung cancer in Norway adequate?</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Norart Open Access</source><creator>Rostad, Hans ; Naalsund, Anne ; Norstein, Jarle ; Jacobsen, Randi ; Aaløkken, Trond Mogens</creator><creatorcontrib>Rostad, Hans ; Naalsund, Anne ; Norstein, Jarle ; Jacobsen, Randi ; Aaløkken, Trond Mogens</creatorcontrib><description>Almost 2,000 new cases of lung cancer are reported in Norway every year. Only 16-17% are operated upon with resection. Over the 1995-98 period, 1,035 not resected cases with localized lung cancer were reported to the Cancer Registry of Norway; 166 cases were excluded for various reasons. Records from the Cancer Registry with additional information from clinicians were revised by the authors with regard to staging and operability. Of 869 evaluable patients, 386 were inoperable due to advanced disease, and in 86 the situation was not adequately clarified. Of the remaining 397, 270 were classified as being operable and 127 possibly operable. Of the operable patients, small cell lung cancer was considered as the sole contraindication to surgery in 61 patients despite being in stage 1. Poor lung function was noted as contraindication to surgery in 50 patients. However, most of them were inadequately investigated. In 124 patients one or more other risk factors were considered as contraindications, but the impact of some of them seemed to have been overestimated. The study showed that the information about stage routinely submitted to the Cancer Registry was unsatisfactory. We believe that more patients with localized disease in the present series should have been operated on.</description><identifier>ISSN: 0029-2001</identifier><identifier>PMID: 12448263</identifier><language>nor</language><publisher>Norway</publisher><subject>Adult ; Aged ; Carcinoma, Small Cell - pathology ; Carcinoma, Small Cell - surgery ; Clinical Competence ; Contraindications ; Humans ; Lung Neoplasms - diagnosis ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Middle Aged ; Neoplasm Staging ; Norway ; Quality of Health Care ; Registries ; Surgical Procedures, Operative - standards</subject><ispartof>Tidsskrift for den Norske Lægeforening, 2002-09, Vol.122 (23), p.2258-2262</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12448263$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rostad, Hans</creatorcontrib><creatorcontrib>Naalsund, Anne</creatorcontrib><creatorcontrib>Norstein, Jarle</creatorcontrib><creatorcontrib>Jacobsen, Randi</creatorcontrib><creatorcontrib>Aaløkken, Trond Mogens</creatorcontrib><title>Is the treatment of lung cancer in Norway adequate?</title><title>Tidsskrift for den Norske Lægeforening</title><addtitle>Tidsskr Nor Laegeforen</addtitle><description>Almost 2,000 new cases of lung cancer are reported in Norway every year. Only 16-17% are operated upon with resection. Over the 1995-98 period, 1,035 not resected cases with localized lung cancer were reported to the Cancer Registry of Norway; 166 cases were excluded for various reasons. Records from the Cancer Registry with additional information from clinicians were revised by the authors with regard to staging and operability. Of 869 evaluable patients, 386 were inoperable due to advanced disease, and in 86 the situation was not adequately clarified. Of the remaining 397, 270 were classified as being operable and 127 possibly operable. Of the operable patients, small cell lung cancer was considered as the sole contraindication to surgery in 61 patients despite being in stage 1. Poor lung function was noted as contraindication to surgery in 50 patients. However, most of them were inadequately investigated. In 124 patients one or more other risk factors were considered as contraindications, but the impact of some of them seemed to have been overestimated. The study showed that the information about stage routinely submitted to the Cancer Registry was unsatisfactory. We believe that more patients with localized disease in the present series should have been operated on.</description><subject>Adult</subject><subject>Aged</subject><subject>Carcinoma, Small Cell - pathology</subject><subject>Carcinoma, Small Cell - surgery</subject><subject>Clinical Competence</subject><subject>Contraindications</subject><subject>Humans</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Norway</subject><subject>Quality of Health Care</subject><subject>Registries</subject><subject>Surgical Procedures, Operative - standards</subject><issn>0029-2001</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j81KAzEYRbNQbK19BcnK3cCXZJJMViLFn0LRTfdDJvlSR-avSQbp21uwXR0uHC6cG7IE4KbgAGxB7lP6Oc9KMXNHFoyXZcWVWBKxTTR_I80Rbe5xyHQMtJuHA3V2cBhpO9DPMf7aE7Uej7PN-PxAboPtEq4vXJH92-t-81Hsvt63m5ddMclSFIKh8155zWTjOSjWeJBWOd44qR1zldBOB_AA0jShlEYZBG2C5CwEDl6syNP_7RTH44wp132bHHadHXCcU625ZoKX7Cw-XsS56dHXU2x7G0_1tVL8Ae5SS68</recordid><startdate>20020930</startdate><enddate>20020930</enddate><creator>Rostad, Hans</creator><creator>Naalsund, Anne</creator><creator>Norstein, Jarle</creator><creator>Jacobsen, Randi</creator><creator>Aaløkken, Trond Mogens</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20020930</creationdate><title>Is the treatment of lung cancer in Norway adequate?</title><author>Rostad, Hans ; Naalsund, Anne ; Norstein, Jarle ; Jacobsen, Randi ; Aaløkken, Trond Mogens</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-31ecdd6d715bd2061bd05a6c2bc57c1c837c7f0d0059bf45969e079f521ff20d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>nor</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Carcinoma, Small Cell - pathology</topic><topic>Carcinoma, Small Cell - surgery</topic><topic>Clinical Competence</topic><topic>Contraindications</topic><topic>Humans</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Norway</topic><topic>Quality of Health Care</topic><topic>Registries</topic><topic>Surgical Procedures, Operative - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rostad, Hans</creatorcontrib><creatorcontrib>Naalsund, Anne</creatorcontrib><creatorcontrib>Norstein, Jarle</creatorcontrib><creatorcontrib>Jacobsen, Randi</creatorcontrib><creatorcontrib>Aaløkken, Trond Mogens</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Tidsskrift for den Norske Lægeforening</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rostad, Hans</au><au>Naalsund, Anne</au><au>Norstein, Jarle</au><au>Jacobsen, Randi</au><au>Aaløkken, Trond Mogens</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is the treatment of lung cancer in Norway adequate?</atitle><jtitle>Tidsskrift for den Norske Lægeforening</jtitle><addtitle>Tidsskr Nor Laegeforen</addtitle><date>2002-09-30</date><risdate>2002</risdate><volume>122</volume><issue>23</issue><spage>2258</spage><epage>2262</epage><pages>2258-2262</pages><issn>0029-2001</issn><abstract>Almost 2,000 new cases of lung cancer are reported in Norway every year. Only 16-17% are operated upon with resection. Over the 1995-98 period, 1,035 not resected cases with localized lung cancer were reported to the Cancer Registry of Norway; 166 cases were excluded for various reasons. Records from the Cancer Registry with additional information from clinicians were revised by the authors with regard to staging and operability. Of 869 evaluable patients, 386 were inoperable due to advanced disease, and in 86 the situation was not adequately clarified. Of the remaining 397, 270 were classified as being operable and 127 possibly operable. Of the operable patients, small cell lung cancer was considered as the sole contraindication to surgery in 61 patients despite being in stage 1. Poor lung function was noted as contraindication to surgery in 50 patients. However, most of them were inadequately investigated. In 124 patients one or more other risk factors were considered as contraindications, but the impact of some of them seemed to have been overestimated. The study showed that the information about stage routinely submitted to the Cancer Registry was unsatisfactory. We believe that more patients with localized disease in the present series should have been operated on.</abstract><cop>Norway</cop><pmid>12448263</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0029-2001
ispartof Tidsskrift for den Norske Lægeforening, 2002-09, Vol.122 (23), p.2258-2262
issn 0029-2001
language nor
recordid cdi_proquest_miscellaneous_72713241
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Norart Open Access
subjects Adult
Aged
Carcinoma, Small Cell - pathology
Carcinoma, Small Cell - surgery
Clinical Competence
Contraindications
Humans
Lung Neoplasms - diagnosis
Lung Neoplasms - pathology
Lung Neoplasms - surgery
Middle Aged
Neoplasm Staging
Norway
Quality of Health Care
Registries
Surgical Procedures, Operative - standards
title Is the treatment of lung cancer in Norway adequate?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T22%3A00%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20the%20treatment%20of%20lung%20cancer%20in%20Norway%20adequate?&rft.jtitle=Tidsskrift%20for%20den%20Norske%20L%C3%A6geforening&rft.au=Rostad,%20Hans&rft.date=2002-09-30&rft.volume=122&rft.issue=23&rft.spage=2258&rft.epage=2262&rft.pages=2258-2262&rft.issn=0029-2001&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72713241%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72713241&rft_id=info:pmid/12448263&rfr_iscdi=true